- Home
- BLRX vs GENK Comparison
BLRX vs GENK Comparison
Compare BLRX & GENK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLRX | GENK |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | Israel | United States |
| Employees | N/A | 2700 |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6M | 12.8M |
| IPO Year | 2010 | 2023 |
Fundamental Metrics
Financial Performance| Metric | BLRX | GENK |
|---|---|---|
| Price | $2.66 | $1.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $19.00 | $4.50 |
| AVG Volume (30 Days) | 10.2K | ★ 20.8K |
| Earning Date | 05-26-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 1.88% |
| EPS Growth | N/A | ★ 62.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $208,380,000.00 |
| Revenue This Year | N/A | $4.79 |
| Revenue Next Year | N/A | $7.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 15.12 |
| 52 Week Low | $2.15 | $1.43 |
| 52 Week High | $4.56 | $4.16 |
Technical Indicators
Market Signals| Indicator | BLRX | GENK |
|---|---|---|
| Relative Strength Index (RSI) | 39.10 | 56.50 |
| Support Level | $2.65 | $1.71 |
| Resistance Level | $2.76 | $2.18 |
| Average True Range (ATR) | 0.16 | 0.12 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 17.84 | 83.95 |
Price Performance
Historical ComparisonAbout BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. The group operates its restaurants in California, Arizona, Hawaii, Nevada, Texas, New York, Oregon, North Carolina, Washington, New Jersey, Florida and South Korea.